Loss of T cell microRNA provides systemic protection against autoimmune pathology in mice

Journal of Autoimmunity

Volumn 38, Issue 1, 2012, Pages 39-48

  Tian, Lei ^a   De Hertogh, Gert ^a   Fedeli, Maya ^b   Staats, Kim A ^a   Schonefeldt, Susann ^a   Humblet Baron, Stephanie ^a,c   Van Den Bosch, Ludo ^a   Dellabona, Paolo ^b   Dooley, James ^a   Liston, Adrian ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Autoimmunity; Dicer; Immune tolerance; MicroRNA; T cells

Indexed keywords

DICER; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; L SELECTIN; MICRORNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLON; CYTOKINE PRODUCTION; HISTOLOGY; INTESTINE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COLON; CYTOKINES; DEAD-BOX RNA HELICASES; FEMALE; FLOW CYTOMETRY; GENE REGULATORY NETWORKS; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEASE III; RNA, MESSENGER; T-LYMPHOCYTES; TH1 CELLS;

EID: 84856630441     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.12.004     Document Type: Article

References (41)

1. Furer V., Greenberg J.D., Attur M., Abramson S.B., Pillinger M.H. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin Immunol 2010, 136;1-15.
2. Ebert P.J., Jiang S., Xie J., Li Q.J., Davis M.M. An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol 2009, 10:1162-1169.
3. Li Q.J., Chau J., Ebert P.J., Sylvester G., Min H., Liu G., et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129:147-161.
4. Yu D., Tan A.H., Hu X., Athanasopoulos V., Simpson N., Silva D.G., et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007, 450:299-303.
5. Weitzel R.P., Lesniewski M.L., Haviernik P., Kadereit S., Leahy P., Greco N.J., et al. microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells. Blood 2009, 113:6648-6657.
6. Huang B., Zhao J., Lei Z., Shen S., Li D., Shen G.X., et al. miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA. EMBO Rep 2009, 10:180-185.
7. Curtale G., Citarella F., Carissimi C., Goldoni M., Carucci N., Fulci V., et al. Anemerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115:265-273.
8. Lu L.F., Boldin M.P., Chaudhry A., Lin L.L., Taganov K.D., Hanada T., et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010, 142:914-929.
9. Boldin M.P., Taganov K.D., Rao D.S., Yang L., Zhao J.L., Kalwani M., et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. JExp Med 2011, 208:1189-1201.
10. Lu L.F., Thai T.H., Calado D.P., Chaudhry A., Kubo M., Tanaka K., et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 2009, 30:80-91.
11. O'Connell R.M., Kahn D., Gibson W.S., Round J.L., Scholz R.L., Chaudhuri A.A., et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010, 33:607-619.
12. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., et al. Regulation of the germinal center response by microRNA-155. Science 2007, 316:604-608.
13. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
14. Steiner D.F., Thomas M.F., Hu J.K., Yang Z., Babiarz J.E., Allen C.D., et al. MicroRNA-29 regulates T-box transcription factors and interferon-gamma production in helper T cells. Immunity 2011, 35:169-181.
15. Ma F., Xu S., Liu X., Zhang Q., Xu X., Liu M., et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 2011, 12:861-869.
16. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 2009, 10:1252-1259.
17. Yu D., Rao S., Tsai L.M., Lee S.K., He Y., Sutcliffe E.L., et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009, 31:457-468.
18. Cobb B.S., Nesterova T.B., Thompson E., Hertweck A., O'Connor E., Godwin J., et al. Tcell lineage choice and differentiation in the absence of the RNase III enzyme dicer. JExp Med 2005, 201:1367-1373.
19. Muljo S.A., Ansel K.M., Kanellopoulou C., Livingston D.M., Rao A., Rajewsky K. Aberrant T cell differentiation in the absence of dicer. JExp Med 2005, 202:261-269.
20. Cobb B.S., Hertweck A., Smith J., O'Connor E., Graf D., Cook T., et al. Arole for dicer in immune regulation. JExp Med 2006, 203:2519-2527.
21. Chong M.M., Rasmussen J.P., Rudensky A.Y., Littman D.R. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. JExp Med 2008, 205:2005-2017.
22. Zhou X., Jeker L.T., Fife B.T., Zhu S., Anderson M.S., McManus M.T., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. JExp Med 2008, 205:1983-1991.
23. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. JExp Med 2008, 205:1993-2004.
24. Wolfer A., Bakker T., Wilson A., Nicolas M., Ioannidis V., Littman D.R., et al. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol 2001, 2:235-241.
25. Yi R., O'Carroll D., Pasolli H.A., Zhang Z., Dietrich F.S., Tarakhovsky A., et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet 2006, 38:356-362.
26. Leveen P., Carlsen M., Makowska A., Oddsson S., Larsson J., Goumans M.J., et al. TGF-beta type II receptor-deficient thymocytes develop normally but demonstrate increased CD8+ proliferation invivo. Blood 2005, 106:4234-4240.
27. Shen C., Bullens D., Kasran A., Maerten P., Boon L., Aerts J.M., et al. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis. Int Immunopharmacol 2004, 4:939-951.
28. Gamsu G., Salmon C.J., Warnock M.L., Blanc P.D. CT quantification of interstitial fibrosis in patients with asbestosis: a comparison of two methods. AJR Am J Roentgenol 1995, 164:63-68.
29. Takada K., Takiguchi M., Konno A., Inaba M. Spontaneous development of multiple glandular and extraglandular lesions in aged IQI/Jic mice: a model for primary Sjogren's syndrome. Rheumatology (Oxford) 2004, 43:858-862.
30. Tarnopolsky M.A., Bourgeois J.M., Snow R., Keys S., Roy B.D., Kwiecien J.M., et al. Histological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and rats. Am J Physiol Regul Integr Comp Physiol 2003, 285:R762-R769.
31. Kyrlagkitsis I., Portmann B., Smith H., O'Grady J., Cramp M.E. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol 2003, 98:1588-1593.
32. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
33. Marie J.C., Liggitt D., Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 2006, 25:441-454.
34. Fedeli M., Napolitano A., Wong M.P., Marcais A., de Lalla C., Colucci F., et al. Dicer-dependent microRNA pathway controls invariant NKT cell development. JImmunol 2009, 183:2506-2512.
35. Asano M., Toda M., Sakaguchi N., Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. JExp Med 1996, 184:387-396.
36. Powrie F., Leach M.W., Mauze S., Menon S., Caddle L.B., Coffman R.L. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994, 1:553-562.
37. Powrie F., Correa-Oliveira R., Mauze S., Coffman R.L. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. JExp Med 1994, 179:589-600.
38. Huber S., Gagliani N., Esplugues E., O'Connor W., Huber F.J., Chaudhry A., et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3 and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 2011, 34:554-565.
39. Dai Y., Huang Y.S., Tang M., Lv T.Y., Hu C.X., Tan Y.H., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16:939-946.
40. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008, 10:R101.
41. Wiesen J.L., Tomasi T.B. Dicer is regulated by cellular stresses and interferons. Mol Immunol 2009, 46:1222-1228.